SCHEMBL7326602

SCHEMBL7326602

O=C(O)c1cc(O)cc2nc3c(O)cccc3nc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.56
ALDH1A1 P00352 4/20 0.54
RAB9A P51151 2/20 0.51
KMT2A Q03164 2/20 0.51
GAA P10253 1/20 0.51
MAPT P10636 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
NQO2 P16083 1/20 0.49
EIF4E P06730 2/20 0.44
EIF4EBP1 Q13541 2/20 0.44
LMNA P02545 1/20 0.43
ALOX12 P18054 1/20 0.43
KDM4E B2RXH2 3/20 0.43
KDM4A O75164 1/20 0.43
EGLN1 Q9GZT9 1/20 0.43
HIF1AN Q9NWT6 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
GRIN2D O15399 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3193693 0.85 ALDH1A1 (0.73) ACHEALDH1A1RAB9AKMT2AGAA
SCHEMBL3724658 0.80 ALDH1A1 (0.71) ACHEALDH1A1RAB9AKMT2AGAA
SCHEMBL30468172 0.80 ALDH1A1 (0.71) ACHEALDH1A1RAB9AKMT2AGAA
SCHEMBL7323456 0.76 ACHE (0.62) ACHEALDH1A1RAB9AKMT2AGAA
SCHEMBL29337446 0.76 ALDH1A1 (0.74) ACHEALDH1A1RAB9AKMT2AGAA
SCHEMBL68995 0.75 ALDH1A1 (0.88) ACHEALDH1A1RAB9AKMT2AGAA
SCHEMBL30548734 0.75 ALDH1A1 (0.88) ACHEALDH1A1RAB9AKMT2AGAA
SCHEMBL3181469 0.75 ACHE (1.00) ACHEALDH1A1RAB9AKMT2AGAA
SCHEMBL29337448 0.75 ALDH1A1 (0.73) ALDH1A1RAB9AKMT2AGAAMAPT
SCHEMBL29337447 0.75 ALDH1A1 (0.73) ALDH1A1RAB9AKMT2AGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4568675-A HYPOTENSIVE AGENT E. R. SQUIBB & SONS, INC. (US) 1986-02-04 US claimed
US-11421223-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. (US) 2022-08-23 US disclosed
US-20190309289-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. 2019-10-10 US disclosed
US-10370654-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. (US) 2019-08-06 US disclosed
US-20180320170-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. 2018-11-08 US disclosed
US-9944925-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. 2018-04-17 US disclosed
US-20160186168-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. 2016-06-30 US disclosed
EP-3027754-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING enEvolv, Inc. (US) 2016-06-08 EP disclosed
WO-2015017866-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. (US) 2015-02-05 WO disclosed
US-5536723-A VASODILATORS BRIGHAM & WOMEN'S HOSPITAL (US) 1996-07-16 US disclosed
US-5356890-A Angiotensin converting enzyme BRIGHAM AND WOMEN'S HOSPITAL (US) 1994-10-18 US disclosed
US-5187183-A Cardiovascular-renal disease; anticoagulants, hypotensive agents; vasodilators; pregnancy toxemia; sclerodema; angiotensin-converting-enzyme inhibitors BRIGHAM & WOMEN'S HOSPITAL (US) 1993-02-16 US disclosed
US-5025001-A S-nitroso derivatives of ACE inhibitors and the use thereof BRIGHAM AND WOMEN'S HOSPITAL (US) 1991-06-18 US disclosed
WO-1989012627-A1 S-NITROSO DERIVATIVES OF ACE INHIBITORS AND THE USE THEREOF BRIGHAM AND WOMEN'S HOSPITAL (US) 1989-12-28 WO disclosed
US-4568675-A HYPOTENSIVE AGENT E. R. SQUIBB & SONS, INC. (US) 1986-02-04 US disclosed
US-4568675-A HYPOTENSIVE AGENT E. R. SQUIBB & SONS, INC. (US) 1986-02-04 US disclosed